Hepatitis C virus-related kidney disease: Various histological patterns

Clinical Nephrology

Volumn 74, Issue 6, 2010, Pages 446-456

  Sumida, K ^a   Ubara, Y ^a   Hoshino, J ^a   Suwabe, T ^a   Nakanishi, S ^a   Hiramatsu, R ^a   Hasegawa, E ^a   Hayami, N ^a   Yamanouchi, M ^a   Sawa, N ^a   Takemoto, F ^a   Takaichi, K ^a   Oohashi, K ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Cryoglobulinemic glomerulopathy; Hepatitis C virus; Immune deposit; Membranoproliferative glomerulonephritis

Indexed keywords

CREATININE; CRYOGLOBULIN; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADRENAL DISEASE; ADULT; AGE; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; GASTROESOPHAGEAL REFLUX; GENDER; HEMATURIA; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HYPERTENSION; HYPOCOMPLEMENTEMIA; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN A NEPHROPATHY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DISEASE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROSCLEROSIS; NEPHROTIC SYNDROME; PROTEIN BLOOD LEVEL; PROTEINURIA; RNA VIRUS; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; AGED; BIOPSY; CHI-SQUARE DISTRIBUTION; COMPLEMENT SYSTEM PROTEINS; CRYOGLOBULINEMIA; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEMATURIA; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; JAPAN; KIDNEY DISEASES; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; NEPHROSIS, LIPOID; PREDICTIVE VALUE OF TESTS; PROTEINURIA; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RNA, VIRAL; TREATMENT OUTCOME;

EID: 78649880410     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.2379/CN106395     Document Type: Article

References (30)

1. Gumber SC, Chopra S. Hepatitis C. a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med. 1995; 123: 615-620.
2. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in Type II Cryoglobulinemia. N Engl J Med. 1992; 327: 1490-1495.
3. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC,Pateron D,MalF,CallardP,Beaugrand M. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet. 1992; 339: 321-323.
4. [4) Ozyilkan E, Ebas T, Simsek H, Telatar F, Kayhan B, Telatar H. Increased prevalence of hepatitis C virus antibodies in patients with diabetes mellitus. J Intern Med. 1994; 35: 283-284. (Pubitemid 24210837)
5. Agnello V, De Rosa F. Extrahepatic disease manifestations ofHCVinfection: some current issues. J Hepatol. 2004; 40: 341-352.
6. D'Amico G. Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis induced by hepatitis C virus. Kidney Int. 1998; 54: 650-671.
7. Johnson R, Gretch D, Yamabe H, Hart J, Bacchi C, Hartwell P, Couser W, Corey L, Wener M, Alpers C, Willson R. Membranoproliferative glomerulonephritis-associated hepatitis C virus infection. N Engl J Med. 1993; 328: 465-470.
8. Yamabe H, Johnson R, Gretch D, Fukushi K,Osawa H, Miyata M, InumaH, SasakiT,Kaizuka M,Tamura N, Tsunoda S, Fujita Y, Onodera K. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol. 1995; 6: 220-223.
9. Okada K, Takishita Y, Shimomura H, Tsuji T, Miyamura T, Kuhara T, Yasutomo K, Kagami S, Kuroda Y. Detection of hepatitis C virus core protein in the glomeruli of patients with membranous glomerulonephritis. Clin Nephrol. 1996; 45: 71-76.
10. McGuire B, Julian B, Bynon J, Cook W, King S, Curtis J, Accortt N, Eckhoff D. Glomerulonephritis in patients with hepatitis C virus cirrhosis undergoing liver transplantation. Ann Intern Med. 2006; 144: 735-740.
11. Chayama K, Tsubota A, Arase Y, Saito S, Koida I, Ikeda K, Matsumoto T, Kobayashi M, Iwasaki S, Koyama S, Morinaga T, Kumada H. Genotype subtyping of hepatitis C virus. J Gastroenterol Hepatol. 1993; 8: 150-156.
12. Kamar N, Izopet J, Alric L, Guilbeaud-Frugier C, Rostaing L. Hepatitis C virus-related kidney disease: an overview. Clin Nephrol. 2008; 69: 149-160.
13. Herrera G, Picken M. Cryoglobulinemic nephropathy. In: Jannette J, Oslon J, Schwartz M, Silva F (eds). Haptinstall's pathology of the Kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 896-900.
14. Pileri P, Uematsu Y, Campagnoli S, GalliG, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. Binding of hepatitis C virus to CD81. Science. 1998; 282: 938-941.
15. Zignego AL, Giannelli F, Marrocchi ME, Mazzocca A, Ferri C, Giannini C, Monti M, Caini P, Villa G, Laffi G, Gentilini P. T(14;18) translocation in chronic hepatitis C virus infection. Hepatology. 2000; 31: 474-479.
16. Roccatello D, Morisica G, Picciotto G, Cesano R, Ropolo R, Bernardi M, Cacace G, Cavalli G, Sena L, Lazzarin A, Piccoli G, Rifai A. Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinemia and hepatitis C virus (HCV) infection. Clin Exp Immunol. 1997; 110: 9-14.
17. Roccatello D, Isidoro C, Mazzucco G, Mesiti A, Quattrocchio G, Amore A, Molino A, Coppo R, Sena L, Piccoli G. Role of monocytes in cryoglo-bulinemia- associated nephritis. Kidney Int. 1993; 43: 1150-1155.
18. Fornasieri A, Li M, Armelloni S, de Septis CP, Schiaffino E, Sinico RA, Schimid C, D'Amico G. Glomerulonephritis induced by human IgMK-IgG cryoglobulins in mice. Lab Invest. 1993; 69: 531-540.
19. Ubara Y, Hara S, Katori H, Tagami T, Kitamura A, Yokota M, Matsushita Y, Takemoto F, Yamada A, Nagahama K, Hara M, Chayama K. Splenectomy may improve the glomerulopathy of Type II mixed cryoglobulinemia. Am J Kidney Dis. 2000; 35: 1186-1192.
20. Koziolek MJ, Scheel A, Bramlage C, Groene HJ, Mueller GA, Strutz F. Effective treatment of hepatitis C-associated immune-complex nephritis with cryoprecipitate apheresis and antiviral therapy. Clin Nephrol. 2007; 67: 245-249.
21. Komatsuda A, Imai H, Wakui H, Hamai K, Ohtani H, Kodama T, Oyama Y, Miura AB, Nakamoto Y. Clinicopathological analysis and therapy in hepatitis C virus-associated nephropathy. Intern Med. 1996; 35: 529-533.
22. Nakamura M, Ohishi A, Watanabe R, Kaneko K, Aosaki N, Iigaya T, Monma T, Sugiura H, Miyoshi Y, Hamaguchi K. IgA nephropathy associated with portal hypertension in liver cirrhosis due to non-alcoholic and non-A, non-B, non-C hepatitis. Intern Med. 1994; 33: 488-491.
23. Babbs C, Warnes T, Torrance H, Ballardie F. IgA nephropathy in non-cirrhotic portal hypertension. Gut 1991; 32: 225-226.
24. De Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001; 5: 645-663.
25. Groszmann R, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff D, Gao H, Makuch R. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005; 353: 2254-2261.
26. Soma J, Saito T, Taguma Y, Chiba S, Satto H, Sugimura K, Ogawa S, Ito S. High prevalence and adverse effect of hepatitis C virus infection in Type 2 diabetic-related nephropathy. J Am Soc Nephrol. 2000; 11: 690-699.
27. Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Kawamura Y, Yatsuji H, Sezaki H, Hosaka T, Hirakawa M, Ikeda K, Kumada H. Sustained virological response reduces incidence of onset of Type 2 diabetes in chronic hepatitis C. Hepatology. 2008; 49: 739-744.
28. Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2006; 15: 2078-2085.
29. Ramos-Casals M, Munos S, Medina F, Jara LJ, Rosas J, Calvo-Alen J, Brito-Zeron P, Forns X, Sanchez-Tapias JM; HISPAMEC Study Group. Systemic autoimmune disease in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry). J Rheumatol. 2009; 36: 1442-1448.
30. Tarantino A, Campise M, Banfi G, Confalonieri R, Bucci A, Montoli A, Colasanti G, Damilano I, D'Amico G, Minetti L, et al. Long-term predictors of survival in essentialmixed cryoglobulinemic glomerulonephritis. Kidney Int. 1995; 47: 618-623.